7 September 2012
A Low-dose ionizing diagnostic radiation to the chest at young age may increase risk of breast cancer in BRCA1/2 mutation carriers
The
Gene-Rad-Risk study reports that ionizing radiation delivered in the course of diagnostic procedures to the chest before age 30 may increase breast cancer risk in women who carry a mutation in the BRCA1 or BRCA2 gene. The findings of the study, coordinated by the
International Agency for Research on Cancer in Lyon, France, were published today online in the
British Medical Journal.
Diagnostic radiation exposure and breast cancer risk among 1,993 BRCA1/2 mutation carriers: a retrospective cohort study (GENE-RAD-RISK).
A Pijpe, N Andrieu, DF Easton, A Kesminiene, E Cardis, et al.
BMJ 2012; 345 doi: 10.1136/bmj.e5660 (Published 6 September 2012
Read Full Text>
Read ArticleRead BMJ Press Release
IARC Monographs Volume 134: Aspartame monograph now available
The monograph on aspartame, the first monograph in IARC Monographs Volume 134: Aspartame, Methyle...
29.04.2024
Read more
Launch of CanScreen5 training in francophone African countries
The International Agency for Research on Cancer (IARC) is pleased to announce the launch of the C...
29.04.2024
Read more
IARC at the International Congress on Occupational Health 2024
Researchers from the International Agency for Research on Cancer (IARC) will present during the 3...
26.04.2024
Read more